Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Insight towards the conserved water mediated recognition of catalytic and structural Zn(+2) ions in human Matrix Metalloproteinase-8 enzyme: A study by MD-simulation methods.
Interferon-γ Activates Nuclear Factor-κ B in Oligodendrocytes through a Process Mediated by the Unfolded Protein Response.
IL-17 induces MIP-1α expression in primary mouse astrocytes via TRPC channel.
Visceral leishmaniasis infection in a fingolimod-treated multiple sclerosis patient.
Cranberry versus placebo in the prevention of urinary infections in multiple sclerosis: a multicenter, randomized, placebo-controlled, double-blind trial.
Retinal nerve fibre layer thinning in patients with clinically isolated optic neuritis and early treatment with interferon-Beta.
Magnetic susceptibility anisotropy: Cylindrical symmetry from macroscopically ordered anisotropic molecules and accuracy of MRI measurements using few orientations.
The Hygiene Theory Harnessing Helminths and Their Ova to Treat Autoimmunity.
Interferon beta-related nephropathy and interstitial lung disease: a new association and a long-term warning.
Cost of disorders of the brain in Spain.
Clinically isolated syndromes suggestive of multiple sclerosis: an optical coherence tomography study.
The specific antigen approach in multiple sclerosis: Can it ever be enough?
Scope and Applications of Nanomedicines for the Management of Multiple Sclerosis.
Severely exacerbated neuromyelitis optica rat model with extensive astrocytopathy by high affinity anti-aquaporin-4 monoclonal antibody.
Anti-inflammatory nutritional intervention in patients with relapsing-remitting and primary-progressive multiple sclerosis: A pilot study.
4-Аminopyridine sequesters intracellular Ca(2+) which triggers exocytosis in excitable and non-excitable cells.
Neuroinflammation as the proximate cause of signature pathogenic pattern progression in amyotrophic lateral sclerosis, AIDS, and multiple sclerosis.
Multiple sclerosis: Month of birth effect in MS-fact or artefact?
Therapeutic potential of a novel cannabinoid agent CB52 in the mouse model of experimental autoimmune encephalomyelitis.
Clinical experiences with cannabinoids in spasticity management in multiple sclerosis.
Choosing the best treatment for multiple sclerosis: comparative effectiveness, safety, and other factors involved in disease-modifying therapy choice.
Diagnostic value of 3D fluid attenuated inversion recovery sequence in multiple sclerosis.
Accurate determination of blood-brain barrier permeability using dynamic contrast-enhanced T1-weighted MRI: a simulation and in vivo study on healthy subjects and multiple sclerosis patients.
Central nervous system B-cell lymphoma in multiple sclerosis.
Internet-based self-help treatment for depression in multiple sclerosis: study protocol of a randomized controlled trial.

Pages